Cadinha & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.83M | Buy |
18,865
+13,670
| +263% | +$4.68M | 1.01% | 29 |
|
|
2026
Q1 | $1.83M | Buy |
5,195
+25
| +0.5% | +$8.91K | 0.34% | 37 |
|
|
2025
Q4 | $1.69M | Buy |
5,170
+100
| +2% | +$31.7K | 0.26% | 39 |
|
|
2025
Q3 | $1.43M | Buy |
5,070
+25
| +0.5% | +$7.25K | 0.19% | 46 |
|
|
2025
Q2 | $1.41M | Sell |
5,045
-62
| -1% | -$17.6K | 0.23% | 42 |
|
|
2025
Q1 | $1.59M | Sell |
5,107
-110
| -2% | -$32.5K | 0.34% | 36 |
|
|
2024
Q4 | $1.36M | Buy |
5,217
+8
| +0.2% | +$2.37K | 0.23% | 41 |
|
|
2024
Q3 | $1.68M | Buy |
5,209
+32
| +0.6% | +$10.5K | 0.29% | 39 |
|
|
2024
Q2 | $1.62M | Buy |
5,177
+167
| +3% | +$49.1K | 0.3% | 38 |
|
|
2024
Q1 | $1.42M | Hold |
5,010
| – | – | 0.24% | 39 |
|
|
2023
Q4 | $1.44M | Sell |
5,010
-875
| -15% | -$238K | 0.23% | 42 |
|
|
2023
Q3 | $1.58M | Buy |
5,885
+970
| +20% | +$242K | 0.35% | 37 |
|
|
2023
Q2 | $1.09M | Sell |
4,915
-26,663
| -84% | -$6.19M | 0.2% | 47 |
|
|
2023
Q1 | $7.63M | Sell |
31,578
-28,028
| -47% | -$6.88M | 2.1% | 19 |
|
|
2022
Q4 | $15.7M | Buy |
59,606
+52,526
| +742% | +$14.1M | 3.5% | 14 |
|
|
2022
Q3 | $1.6M | Hold |
7,080
| – | – | 0.54% | 22 |
|
|
2022
Q2 | $1.72M | Sell |
7,080
-1,120
| -14% | -$274K | 0.39% | 30 |
|
|
2022
Q1 | $1.98M | Sell |
8,200
-1,190
| -13% | -$273K | 0.29% | 38 |
|
|
2021
Q4 | $2.11M | Sell |
9,390
-72,315
| -89% | -$15.3M | 0.28% | 39 |
|
|
2021
Q3 | $17.4M | Buy |
81,705
+1,059
| +1% | +$244K | 2.48% | 22 |
|
|
2021
Q2 | $19.7M | Buy |
80,646
+1,138
| +1% | +$280K | 2.64% | 17 |
|
|
2021
Q1 | $19.8M | Sell |
79,508
-5,965
| -7% | -$1.42M | 2.85% | 13 |
|
|
2020
Q4 | $19.7M | Buy |
85,473
+1,821
| +2% | +$420K | 2.72% | 17 |
|
|
2020
Q3 | $21.3M | Buy |
83,652
+1,443
| +2% | +$357K | 3.69% | 9 |
|
|
2020
Q2 | $19.4M | Buy |
82,209
+2,434
| +3% | +$555K | 3.3% | 10 |
|
|
2020
Q1 | $16.2M | Buy |
79,775
+72,714
| +1,030% | +$15.9M | 4.29% | 8 |
|
|
2019
Q4 | $1.7M | Buy |
7,061
+65
| +0.9% | +$14.3K | 0.24% | 59 |
|
|
2019
Q3 | $1.35M | Sell |
6,996
-244
| -3% | -$46.8K | 0.22% | 56 |
|
|
2019
Q2 | $1.33M | Sell |
7,240
-70,408
| -91% | -$12.6M | 0.24% | 56 |
|
|
2019
Q1 | $14.8M | Buy |
77,648
+1,817
| +2% | +$347K | 2.89% | 14 |
|
|
2018
Q4 | $14.8M | Buy |
75,831
+53,345
| +237% | +$10.4M | 3.66% | 9 |
|
|
2018
Q3 | $4.66M | Buy |
22,486
+20
| +0.1% | +$3.94K | 0.74% | 30 |
|
|
2018
Q2 | $4.15M | Buy |
22,466
+7,175
| +47% | +$1.27M | 0.76% | 28 |
|
|
2018
Q1 | $2.61M | Sell |
15,291
-29,829
| -66% | -$5.48M | 0.53% | 33 |
|
|
2017
Q4 | $7.85M | Buy |
45,120
+32,334
| +253% | +$5.72M | 1.08% | 37 |
|
|
2017
Q3 | $2.38M | Buy |
12,786
+1,500
| +13% | +$266K | 0.41% | 42 |
|
|
2017
Q2 | $1.94M | Buy |
11,286
+1,950
| +21% | +$317K | 0.34% | 42 |
|
|
2017
Q1 | $1.53M | Buy |
9,336
+100
| +1% | +$16.6K | 0.3% | 45 |
|
|
2016
Q4 | $1.35M | Sell |
9,236
-200
| -2% | -$30.1K | 0.23% | 43 |
|
|
2016
Q3 | $1.57M | Hold |
9,436
| – | – | 0.32% | 45 |
|
|
2016
Q2 | $1.44M | Hold |
9,436
| – | – | 0.31% | 46 |
|
|
2016
Q1 | $1.42M | Buy |
9,436
+936
| +11% | +$139K | 0.36% | 41 |
|
|
2015
Q4 | $1.38M | Buy |
8,500
+2,200
| +35% | +$346K | 0.33% | 43 |
|
|
2015
Q3 | $871K | Sell |
6,300
-49
| -0.8% | -$7.72K | 0.21% | 51 |
|
|
2015
Q2 | $975K | Buy |
6,349
+49
| +0.8% | +$7.85K | 0.19% | 55 |
|
|
2015
Q1 | $1.01M | Hold |
6,300
| – | – | 0.2% | 55 |
|
|
2014
Q4 | $1M | Hold |
6,300
| – | – | 0.17% | 57 |
|
|
2014
Q3 | $885K | Sell |
6,300
-20
| -0.3% | -$2.61K | 0.16% | 61 |
|
|
2014
Q2 | $748K | Sell |
6,320
-400
| -6% | -$46.3K | 0.13% | 67 |
|
|
2014
Q1 | $829K | Hold |
6,720
| – | – | 0.15% | 62 |
|
|
2013
Q4 | $767K | Sell |
6,720
-100
| -1% | -$11.4K | 0.14% | 60 |
|
|
2013
Q3 | $763K | Hold |
6,820
| – | – | 0.15% | 54 |
|
|
2013
Q2 | $673K | Buy |
+6,820
| New | +$708K | 0.15% | 48 |
|
Other funds holding AMGN
Cadinha & Co's AMGN Position: Q2 2026 in Review
Cadinha & Co increased its Amgen (AMGN) stake by 263% in Q2 2026, buying an estimated $4.68M and bringing the position to 18,865 shares worth $6.83M. The position accounts for 1.01% of the portfolio, ranked #29.
Cadinha & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.3M in Q3 2020. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cadinha & Co held 18,865 shares of Amgen worth $6.83M as of Q2 2026.
- Cadinha & Co bought 13,670 Amgen shares in Q2 2026, an estimated $4.68M.
- Amgen made up 1.01% of Cadinha & Co's portfolio in Q2 2026, its #29 holding.
- Cadinha & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- Cadinha & Co's Amgen position peaked at $21.3M in Q3 2020.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cadinha & Co's 13F filing for Q2 2026, filed 28 Jul 2026.